Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,315.00
Bid: 1,343.00
Ask: 1,351.00
Change: 30.00 (2.33%)
Spread: 8.00 (0.596%)
Open: 1,310.00
High: 1,349.00
Low: 1,271.00
Prev. Close: 1,285.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: Indivior Surges 25% On Upgraded Guidance

Thu, 11th Jul 2019 10:32

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Barratt Developments, up 3.5%, Taylor Wimpey, up 1.7%, Persimmon, up 1.3%, Berkeley Group, up 1.2%. Shares in the housebuilders were higher following the latest results from the Royal Institution of Chartered Surveyors UK Residential Market Survey. Appetite for buying a home has picked up for the first time in nearly three years, surveyors have reported. An overall net balance of 10% more surveyors saw an increase rather than a decrease in interest from new buyers in June, according to RICS. There are also signs of a more stable trend in the supply of homes coming on the market, RICS said. For the first time in a year, surveyors are seeing positive growth in properties being listed for sale. "Investors raced to snap up shares in housebuilders after the latest RICS survey showed some signs of recovery in the housing market. Although it is too early to call a bounce-back in the property market based on one set of data, the news does offer a glimmer of hope for investors in housebuilding stocks," AJ Bell's Russ Mould said.----------Reckitt Benckiser, up 2.8%. The consumer goods firm said it agreed with the US Department of Justice and the Federal Trade Commission to resolve an investigation into the sales and marketing of Suboxone Film by former prescription pharmaceuticals arm Indivior. In September 2016, 35 US states and the District of Columbia filed a civil complaint against Indivior in relation to its ongoing legal privilege dispute with the US Federal Trade Commission. Since then, the commission has been investigating whether Indivior, then owned by former parent Reckitt, tried to prevent generic competition for its Suboxone Film opioid addiction treatment. The firm on Thursday said it will pay up to USD1.4 billion to fully resolve all federal investigations into Reckitt in connection with the Indivior indictment and claims relating to state Medicaid programs for those states choosing to participate in the settlement. ----------FTSE 100 - LOSERS----------Halma, down 1.0%. The stock went ex-dividend meaning new buyers no longer qualify for the latest payout. ----------Experian, down 0.8%. Goldman Sachs cut the credit checking agency to Neutral from Buy. ----------FTSE 250 - WINNERS----------Diploma, up 5.5%. The technical products and services firm announced the GBP56.0 million takeover of a gasket and fluid-sealing products maker. Virginia Sealing Products Inc specialises in customers who process and transport hazardous materials but also operates in markets such as power generation, pulp & paper, and marine. Diploma is paying GBP56.0 million in cash upfront, but it may also pay a further GBP8.0 million if VSP meets various operating profit targets. The deal will be funded from existing cash and new debt, but Diploma said it "will continue to maintain a strong balance sheet". ----------John Wood, up 3.8%. Bernstein promoted the oilfield services firm to its Top Pick within its oil sector coverage. ----------FTSE 250 - LOSERS----------Telecom Plus, down 1.0%. The stock went ex-dividend. ----------OTHER MAIN MARKET AND AIM - WINNERS----------Indivior, up 25%. The pharmaceuticals firm revised its expectations for 2019 net revenue and net income higher following a stronger-than-expected first half. Indivior highlighted that the primary driver of growth has been the market share outperformance of Suboxone Film. Indivior said it now expects net revenue for 2019 to be in a range of USD670 million to USD720 million and net income in a range of USD80 million to USD130 million. The company had previously expected net revenue to come in between USD525 million and USD575 million, and net income was not seen higher than USD10 million. In 2018, Indivior delivered net revenue of USD1.00 billion and net income of USD275 million. ----------Sosandar, up 12% at 16.25p. The online women's fashion retailer said it has raised GBP7 million at a premium to push forward with future growth. Sosandar placed approximately 46.7 million shares at 15 pence per share. Sosandar said the placing price represented a 3.4% premium to Thursday's closing price. The placing comprises of a firm placing of 22.7 million shares with a further placing of 24.0 million shares, conditional on shareholder approval. Sosandar said the placing was needed to raise additional equity to "help support and accelerate further growth".----------OTHER MAIN MARKET AND AIM - LOSERS----------Tekcapital, down 27% at 8.25p. The investment company focused on university-developed technology said it intends to raise GBP750,000 through a share placing to fund investment in key activities and to further develop and progress with the commercialisation of its portfolio of intellectual property. The AIM-listed firm said it will issue 9.4 million shares at a price of 8 pence each. Following the admission, Tekcapital will have 63.7 million shares overall. A significant amount of the placing will be utilised to expand Tekcapital's commercialisation of its investment portfolio of businesses, the company highlighted.----------

More News
19 Nov 2020 10:30

Indivior Promotes Former Shire CFO Graham Hetherington To Chair

Indivior Promotes Former Shire CFO Graham Hetherington To Chair

Read more
13 Nov 2020 17:21

LONDON MARKET CLOSE: Vaccine Enthusiasm Fades As Case Numbers Rise

LONDON MARKET CLOSE: Vaccine Enthusiasm Fades As Case Numbers Rise

Read more
13 Nov 2020 11:13

UK WINNERS & LOSERS SUMMARY: Galliford Rises As Dividend Set To Return

UK WINNERS & LOSERS SUMMARY: Galliford Rises As Dividend Set To Return

Read more
13 Nov 2020 08:19

Indivior Happy To Put Suboxone Matter Behind It As Court Approves Deal

Indivior Happy To Put Suboxone Matter Behind It As Court Approves Deal

Read more
13 Nov 2020 07:45

LONDON MARKET PRE-OPEN: Galliford Try Expects To Reinstate Dividends

LONDON MARKET PRE-OPEN: Galliford Try Expects To Reinstate Dividends

Read more
13 Nov 2020 07:03

Indivior's settlement with DoJ approved by US court

(Sharecast News) - Indivior said a US court approved its agreement with the Department of Justice and other agencies and dismissed charges related to sales of its Suboxone opioid addiction treatment.

Read more
29 Oct 2020 12:50

Indivior Q3 profit, revenue decline; new FY guidance outlined

(Sharecast News) - Indivior reported a decline in third-quarter revenue and operating profit on Thursday but reinstated financial guidance as it said it expects to be profitable on an adjusted pre-tax basis for FY 2020.

Read more
29 Oct 2020 12:02

Indivior Reinstates Annual Guidance; Quarterly Profit Falls 79%

Indivior Reinstates Annual Guidance; Quarterly Profit Falls 79%

Read more
23 Oct 2020 10:40

Indivior Says Former CEO Thaxter's US Sentencing Not Related

Indivior Says Former CEO Thaxter's US Sentencing Not Related

Read more
23 Oct 2020 08:19

Former Indivior CEO sentenced in US Federal Court

(Sharecast News) - Pharmaceutical firm Indivior revealed on Friday that former chief executive Shaun Thaxter had been sentenced in United States Federal Court.

Read more
22 Oct 2020 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
24 Sep 2020 10:44

Indivior Reorganises Amid Challenges; Still In Line With Expectations

Indivior Reorganises Amid Challenges; Still In Line With Expectations

Read more
24 Sep 2020 08:35

Indivior to axe jobs, restructure as it looks to cut costs

(Sharecast News) - Opioid addiction treatment maker Indivior outlined plans on Thursday to reduce costs through job cuts and restructuring, as it looks to support long-term growth ambitions and protect its financial and operational flexibility in response to the pandemic.

Read more
4 Sep 2020 17:57

IN BRIEF: Indivior Chair Howard Pien Steps Down Immediately

IN BRIEF: Indivior Chair Howard Pien Steps Down Immediately

Read more
2 Sep 2020 19:36

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.